trimethoprim--sulfamethoxazole-drug-combination and Endocarditis

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Endocarditis* in 2 studies

Reviews

2 review(s) available for trimethoprim--sulfamethoxazole-drug-combination and Endocarditis

ArticleYear
Infective endocarditis by
    Journal of chemotherapy (Florence, Italy), 2023, Volume: 35, Issue:3

    Nocardiosis, is a potentially life-threatening disease, especially in immunocompromised individuals where it manifests as a disseminated disease. Infective Endocarditis (IE) is a rare disease with significant morbidity and mortality. Importantly, even though there are scarce data of IE by

    Topics: Anti-Bacterial Agents; Endocarditis; Endocarditis, Bacterial; Humans; Nocardia; Trimethoprim, Sulfamethoxazole Drug Combination

2023
Listeriosis: recognizing it, treating it, preventing it.
    Cleveland Clinic journal of medicine, 1999, Volume: 66, Issue:6

    Listeria monocytogenes has become a major pathogen in foodborne illness. It most often affects patients who are pregnant, at the extremes of life, or immunocompromised in some way. A variety of clinical manifestations are possible, but bacteremia and meningitis are most common. This article reviews the epidemiology, microbiology, populations at risk, clinical manifestations, treatment, and prevention of listeriosis.

    Topics: Adolescent; Adult; Age Distribution; Aged; Ampicillin; Bacteremia; Child; Child, Preschool; Endocarditis; Erythromycin; Female; Foodborne Diseases; Gastroenteritis; Humans; Incidence; Infant; Infant, Newborn; Listeria monocytogenes; Listeriosis; Male; Meningitis; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

1999